Genomics

Dataset Information

0

Targeted Inhibition of Purine Metabolism is Effective in Suppressing Hepatocellular Carcinoma Progression


ABSTRACT: Tumor-specific metabolic rewiring, intended to confer a survival advantage over non-transformed cells, often offers an opportunity to target cancers. Here, we identify deregulated expression of purine biosynthetic enzymes as a metabolic hallmark in human hepatocellular carcinomas (HCC), with the extent of enzyme upregulation a predictor of clinical outcome. We demonstrate in HCC cell lines, patient-derived xenograft (PDX) organoids and mouse models that inhibition of purine biosynthesis abrogated cancer cell proliferation and tumor growth. Mechanistically, a PI3K-E2F1 axis coordinated purine biosynthetic enzyme expression. Clinically approved inhibitors against PI3K and the purine biosynthetic rate-limiting enzyme IMPDH synergistically reduced the tumor burden in a PDX mouse model. Collectively, our results support targeting purine metabolic reprogramming as a precision therapeutic strategy for HCC patients.

ORGANISM(S): Homo sapiens

PROVIDER: GSE145988 | GEO | 2020/07/06

REPOSITORIES: GEO

Similar Datasets

2013-10-01 | E-GEOD-51277 | biostudies-arrayexpress
2013-10-01 | GSE51277 | GEO
2013-10-01 | E-GEOD-51278 | biostudies-arrayexpress
2013-10-01 | GSE51278 | GEO
2012-05-01 | GSE29202 | GEO
2023-05-09 | GSE229656 | GEO
2023-05-09 | GSE229550 | GEO
| PRJNA522787 | ENA
2014-02-01 | E-GEOD-48394 | biostudies-arrayexpress
2021-04-28 | GSE173410 | GEO